Microbiology of surgical site infections complicating breast surgery

Surgical Infections

Volumn 11, Issue 4, 2010, Pages 355-359

  Throckmorton, Alyssa D ^a   Baddour, Larry M ^a   Hoskin, Tanya L ^a   Boughey, Judy C ^a   Degnim, Amy C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEFAZOLIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; MINOCYCLINE; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AXILLA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; BREAST SURGERY; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; CORYNEBACTERIUM AVIDUM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMPIRICISM; ENTEROBACTER AEROGENES; ENTEROCOCCUS; FEMALE; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIDRUG RESISTANCE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPIONIBACTERIUM; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS; SURGICAL INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BREAST; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 77955613771     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2009.029     Document Type: Article

References (14)

1. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial. Ann Surg Oncol 2006;13:491-500.
2. Vilar-Compte D, Jacquemin B, Robles-Vidal C, et al. Surgical site infections in breast surgery: Case-control study. World J Surg 2004;28:242-246.
3. Weiss CA 3rd, Statz CL, Dahms RA, et al. Six years of surgical wound infection surveillance at a tertiary care center: Review of the microbiologic and epidemiological aspects of 20,007 wounds. Arch Surg 1999;134:1041-1048.
4. Gaynes RP, Culver DH, Horan TC, et al. Surgical site infection (SSI) rates in the United States, 1992-1998: The National Nosocomial Infections Surveillance System Basic SSI Risk Index. Clin Infect Dis 2001;33(Suppl 2):S69-S77.
5. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609.
6. Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 2007;25:3657-3663.
7. Beatty JD, Robinson GV, Zaia JA, et al. A prospective analysis of nosocomial wound infection after mastectomy. Arch Surg 1983;118:1421-1424.
8. Chen J, Gutkin Z, Bawnik J. Postoperative infections in breast surgery. J Hosp Infect 1991;17:61-65.
9. Rotstein C, Ferguson R, Cummings M, et al. Determinants of clean surgical wound infections for breast procedures at an oncology center. Infect Control Hosp Epidemiol 1992;13: 207-214.
10. Felippe WA, Werneck GL, Santoro-Lopes G. Surgical site infection among women discharged with a drain in situ after breast cancer surgery. World J Surg 2007;31:2293-2299.
11. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-278.
12. Madaras-Kelly KJ, Arbogast R, Jue S. Increased therapeutic failure for cephalexin versus comparator antibiotics in the treatment of uncomplicated outpatient cellulitis. Pharma- cotherapy 2000;20:199-205.
13. Anderson DJ, Sexton DJ, Kanafani ZA, et al. Severe surgical site infection in community hospitals: Epidemiology, key procedures, and the changing prevalence of methicillin- resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28:1047-1053.
14. Boucher HW, Corey GR. Epidemiology of methicillin- resistant Staphylococcus aureus. Clin Infect Dis 2008;46(Suppl 5):S344-S349.